title: Microbial keratitis trends following refractive surgery: results of the ASCRS infectious keratitis survey and comparisons with prior ASCRS surveys of infectious keratitis following keratorefractive procedures.
abstract: In 2008, the American Society of Cataract and Refractive Surgery (ASCRS) surveyed its 9121 United States and international members to evaluate the changing trends and incidence, culture results, treatment, and visual outcomes of infectious keratitis following keratorefractive procedures worldwide. This paper presents and analyzes the results with comparisons to the data in surveys conducted in 2001 and 2004. Nineteen infections were reported by 14 surgeons who had performed an estimated 20,941 keratorefractive procedures, an incidence of 1 infection in every 1102 procedures. Sixteen cases presented in the first postoperative week, 1 case during the second week, 1 case between the second and fourth weeks, and 1 case at 1 month or later. The 16 cases that presented in the first week were diagnosed at initial presentation. The most common organism cultured was methicillin-resistant Staphylococcus aureus (MRSA). Microbial keratitis following refractive surgery is an increasingly recognized sight-threatening complication.
authors.affiliation: Department of Ophthalmology, NYU Medical Center, New York, New York, USA. rensight@yahoo.com
authors.forename: Renée
authors.initials: R
authors.lastname: Solomon
authors.forename: Eric D
authors.initials: ED
authors.lastname: Donnenfeld
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Holland
authors.forename: Sonia H
authors.initials: SH
authors.lastname: Yoo
authors.forename: Sheraz
authors.initials: S
authors.lastname: Daya
authors.forename: José L
authors.initials: JL
authors.lastname: Güell
authors.forename: Francis S
authors.initials: FS
authors.lastname: Mah
authors.forename: Stephen V
authors.initials: SV
authors.lastname: Scoper
authors.forename: Terry
authors.initials: T
authors.lastname: Kim
mesh_terms: D000890:Anti-Infective Agents / Q000008:administration & dosage; D001419:Bacteria / Q000302:isolation & purification; D001431:Bacteriological Techniques; D003320:Corneal Ulcer / Q000453:epidemiology* / Q000382:microbiology* / Q000628:therapy; D015818:Eye Infections, Bacterial / Q000453:epidemiology* / Q000382:microbiology / Q000628:therapy; D015821:Eye Infections, Fungal / Q000453:epidemiology* / Q000382:microbiology / Q000628:therapy; D006306:Health Surveys; D006801:Humans; D015994:Incidence; D015948:Keratoplasty, Penetrating; D009885:Ophthalmology / Q000706:statistics & numerical data; D054140:Refractive Surgical Procedures / Q000009:adverse effects / Q000639:trends*; D012955:Societies, Medical / Q000706:statistics & numerical data; D014481:United States / Q000453:epidemiology; D014792:Visual Acuity / Q000502:physiology
chemical_list: D000890:Anti-Infective Agents